Siemens Healthcare has introduced new Biograph Horizon PET/CT system, developed to address a wide range of clinical indications.
The new system enables the use of all commercially available PET tracers, providing clinicians with capability to address more indications in the specialist fields of oncology, neurology and cardiology.
Biograph Horizon uses 4mm LSO crystals to offer rapid scintillation with enhanced output, offering better image quality using the lowest achievable dose to help clinicians with visualising small lesions.
The system also includes built-in capabilities, which automate routine tasks to increase productivity and streamline workflows.
The Quanti-QC system is said to run quality control procedures overnight to save clinic time, while scans can be carried out in five minutes, and reconstruction runs besides acquisition for image delivery just 30 seconds after the scan.
Siemens Healthcare sales director Steve Holmes said: "At a time when there is a demand to drive down cost while enhancing productivity, Siemens is well placed to support with technology capable of improving care pathways and maximising investments."
In addition, the system uses syngo.via molecular imaging workplace image processing solution to expand clinical possibilities.
It provides automated tools to instantly visualize diagnostic information, automate pre-fetching, pre-processing, and display and comparison of previous findings.
The Alpha technology offers automatic registration with organ-based recognition capabilities and EQ/PET feature provides precise calculation of changes in tumour uptake.
Image: Siemens Healthcare’s new Biograph Horizon PET/CT system. Photo: courtesy of Siemens AG.